Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Underwriting lethal genetic diseases.

Journal of insurance medicine (New York, N.Y.) - 1 Jan 1998

Lowden J A

Abstract excerpt

There are thousands of single gene deposits that cause increased morbidity or mortality risks. Few have complete penetrance leading to certain death. Most can be underwritten with affordable increases in premium; many at standard rates. As we learn more about penetrance for specific mutations we can learn to be more aggressive in underwriting inherited risks. I have described approaches to underwriting untested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Diseases, Inborn
Share to Genetic Testing
Share to Huntington Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Insurance, Health

Share to Mutation

Share to Neoplasms

Share to United States

Source

Identifiers

PMID: 10186441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Underwriting lethal genetic diseases.PMID 10186441Read ↗

Flunk the gene test and lose your insurance.Semantic proximity Read ↗

Insurance underwriting in the genetic era.Semantic proximity Read ↗

Tackling the achilles' heel of genetic testing.Semantic proximity Read ↗

Today's multiple choice exam: (a) gene duplication; (b) structural mutation; (c) co-option; (d) regulatory mutation; (e) all of the above.Semantic proximity Read ↗

Insurers keep genetic test options open.Semantic proximity Read ↗

Homozygosity mapping: a game-changer for autosomal recessive diseases.Semantic proximity Read ↗

Genetic Discrimination and Health Insurance: An Urgent Need for ReformSemantic proximity Read ↗

Using human genetics to make new medicines.Semantic proximity Read ↗

Walking the ethical highwire: genetic screening and hereditary tyrosinemia.Semantic proximity Read ↗

On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease.Semantic proximity Read ↗

Playing the odds: health insurers want to know what's in your DNA.Semantic proximity Read ↗

Genetic disability: a modest proposal to modify the ADA to protect against some forms of genetic discrimination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.